Alderley Park · GLP bioanalysis since 2012
Regulated bioanalysis, published as a datasheet not a brochure.

MHRA GLP Compliance Programme member and UKAS ISO/IEC 17025 accredited. LC-MS/MS and ligand-binding bioanalysis with a QA unit fully independent of study conduct.
On the datasheet
- MHRA GLP Compliance Programme member
- UKAS accredited to ISO/IEC 17025
- Method validation to ICH M10 (2022)
- QA unit independent of study conduct
Methods
Five assays, specified in full
Analyte, matrix, platform and validated range for each method. The validation report carries the precision and accuracy data.
LC-MS/MS Small Molecule Bioanalysis
- Analyte
- Small-molecule drug & metabolite
- Matrix
- Plasma, serum, urine
- Platform
- LC-MS/MS (triple-quadrupole)
- LLOQ
- Low pg/mL–ng/mL, analyte-dependent
- Validated
- ICH M10 (2022)
Ligand-Binding Assays (LBA)
- Analyte
- Large-molecule therapeutic / biomarker
- Matrix
- Serum, plasma
- Platform
- ELISA / electrochemiluminescence
- LLOQ
- Assay-dependent, fixed at validation
- Validated
- ICH M10, large-molecule provisions
PK/TK Study Bioanalysis
- Analyte
- Study-defined PK/TK analyte
- Matrix
- Per study protocol
- Platform
- LC-MS/MS or LBA, per method
- LLOQ
- Per validated method
- Validated
- GLP or non-GLP, per study
Immunogenicity Testing (ADA/NAb)
- Analyte
- Anti-drug antibody (ADA) / NAb
- Matrix
- Serum, plasma
- Platform
- Tiered screen / confirm / titre
- LLOQ
- Cut-point set per assay
- Validated
- Tiered strategy, current guidance
Method Development & Validation
- Analyte
- Novel analyte / bespoke matrix
- Matrix
- Study-defined
- Platform
- Developed from first principles
- LLOQ
- Established during development
- Validated
- Full ICH M10 on completion
Services
Everything we run
Typical prices, set out before a study starts.
- 01LC-MS/MS Small Molecule Bioanalysis £8,400
Quantitative small-molecule bioanalysis by LC-MS/MS, validated to ICH M10, LLOQ down to pg/mL.
- 02Ligand-Binding Assays (LBA) £11,200
Ligand-binding assay development and validation for large-molecule and biomarker quantification.
- 03PK/TK Study Bioanalysis £95
Sample analysis support for pharmacokinetic and toxicokinetic studies, GLP and non-GLP.
- 04Immunogenicity Testing (ADA/NAb) £13,500
Anti-drug antibody and neutralising antibody assay development for biologics immunogenicity assessment.
- 05Method Development & Validation £6,500
Bespoke bioanalytical method development where no validated method exists for a novel analyte or matrix.
- 06Sample Management & Storage £4
Chain-of-custody sample receipt, -80°C storage and controlled-drugs handling under Home Office licence.
- 07GLP Study Reporting & QA Audit £2,800
Full GLP study reporting with independent QA unit audit at defined study milestones.
Record
- Years running GLP bioanalytical studies
- 13
- Validated bioanalytical methods on file
- 340+
- Typical turnaround, working days, from sample receipt
- 15
- Studies with QA unit independent of conduct
- 100%
Study lifecycle
Five stages in order.
- 01
Feasibility & scoping
We assess the analyte, matrix and regulatory context before quoting a method development or validation scope.
- 02
Method development
A bespoke or platform method is developed and pre-validated against ICH M10 criteria.
- 03
Full validation
Full method validation is completed and a validation report issued ahead of sample analysis.
- 04
Sample analysis
Study samples are analysed against the validated method, tracked against the agreed turnaround.
- 05
QA audit & reporting
The independent QA unit audits protocol, raw data and final report before issue to the sponsor.
Laboratory
Where the work happens

01Sample receiptChain-of-custody sample receipt and logging. 
02Ligand-binding assay benchELISA plate work for a large-molecule bioanalytical method. 
03Method developmentDeveloping and pre-validating a method against ICH M10 criteria. 
04LC-MS/MS suiteTriple-quadrupole LC-MS/MS instrumentation in the Alderley Park laboratory. 
05Sample preparationSample preparation ahead of analysis under the GLP quality system. 
06Sample analysisStudy samples analysed against the validated method.
Sponsors
What Alderley Park says
The validation report gave us the full precision and accuracy dataset, not a one-line summary. Our regulatory submission team could use it directly.
Having a QA unit that genuinely reports outside the study team's line management made a difference during our own sponsor audit, the inspectors noticed.
We needed a bespoke method for an unusual matrix at short notice. Alderwood scoped and quoted it in two days rather than the two weeks we'd been quoted elsewhere.
Fifteen working days turnaround was quoted and met on every batch across a six-month study. No slippage, no surprises in the final report.
Inspections and standards
Questions sponsors ask
Is your laboratory MHRA GLP inspected, and when was the last inspection?
We're a member of the MHRA GLP Compliance Programme and are subject to periodic inspection against the OECD Principles of Good Laboratory Practice. Our most recent inspection was in March 2025; inspection history and status is available to prospective sponsors on request.
What guideline do you validate bioanalytical methods against?
Method validation follows ICH M10 (2022), the current internationally harmonised bioanalytical method validation guideline, adopted by MHRA, EMA and FDA. It replaced the previously separate EMA and FDA guidances, and is the standard we apply across every method regardless of which agency the study ultimately reports to.
How is your QA function kept independent of study conduct?
Our QA unit reports to the Managing Director, entirely outside the study director and analytical team's line management, in line with GLP principles. QA audits protocol, raw data and the final report at defined milestones and can raise a finding without needing sign-off from the study team.
Do you hold a Human Tissue Authority licence?
No, our routine bioanalytical work handles blood, plasma, urine and similar matrices, which fall outside the scope of material requiring an HTA licence. Where a study involves a tissue type that would bring it into HTA scope, we assess and advise on the applicable licensing on a study-by-study basis before accepting the work.
- Alderley Park Bioscience Campus, Alderley Park, SK10 4TR
- Mon–Thu 08:00–18:00Fri 08:00–17:00Sat–Sun Closed